Dr Jonathan Silcock
Joint Chief Investigator
Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) studies medicines management for patients with heart failure across a range of health organisations involved in their care in the National Health Service (NHS). We are funded by the National Institute for Health Research (NIHR) through its Programme Grants for Applied Health Research. Our focus is on working with patients and healthcare staff to develop and test a Medicines at Transitions Toolkit (MaTT) to improve the management of medicines across care transitions (e.g. when patients move between hospital and home).
We are a multidisciplinary research collaboration between University of Bradford and University of Leeds involving academics, patients, the NHS and the NIHR Clinical Research Network.
The ISCOMAT study began in March 2016 and will last for six years until March 2022.
Disclaimer: This project is funded by the National Institute for Health Research (NIHR) programme. Improving the safety and continuity of medicines management at care transitions (ISCOMAT) RP-PG-0514-20009. The views expressed are those of the research team and not necessarily those of the NIHR or the Department of Health and Social Care.
Our research is guided by our Patient-led steering group, Chaired by Mr Robert Turner. They have a specific role in our research, which is as follows:
To contact our patient-led steering group, please get in touch with Hanif Ismail h.ismail11@bradford.ac.uk.
Joint Chief Investigator
Joint Chief Investigator
Programme Manager
Programme team
Patient researcher, programme team
Senior Researcher
University of Bradford
University of Leeds
University of Leeds
University of Leeds
University of Leeds
University of Leeds
University of Leeds
Bradford Institute of Health Research
University of Bradford
You can learn about how Bradford Teaching Hospitals NHS Foundation Trust and the NHS Health Research Authority considers your privacy by viewing the following notices: